Detalhe da pesquisa
1.
Cardiometabolic health in people with HIV: expert consensus review.
J Antimicrob Chemother
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38656584
2.
Hepatic steatosis in people older and younger than fifty who are living with HIV and HIV-negative controls: A cross-sectional study nested within the POPPY cohort.
HIV Med
; 25(1): 95-106, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37670375
3.
Depression is associated with poor self-reported adherence to antiretroviral therapy among people living with HIV attending an HIV clinic in the UK: results from a cross-sectional study.
AIDS Care
; : 1-8, 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289649
4.
The association between single-nucleotide polymorphisms within type 1 interferon pathway genes and human immunodeficiency virus type 1 viral load in antiretroviral-naïve participants.
AIDS Res Ther
; 21(1): 27, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38698440
5.
FRAX assessment in people ageing with HIV.
HIV Med
; 23(1): 103-108, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34541758
6.
HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe.
HIV Med
; 23(6): 684-692, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34882940
7.
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study.
HIV Med
; 23(6): 585-598, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34889022
8.
Factors associated with overweight/obesity in a cohort of people living with HIV over 50 years of age.
AIDS Care
; 34(4): 542-544, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34082628
9.
The benefits of tenofovir discontinuation with or without bisphosphonate therapy in osteoporotic people living with HIV.
HIV Med
; 22(9): 816-823, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34258828
10.
Risky Alcohol Consumption and Associated Health Behaviour Among HIV-Positive and HIV-Negative Patients in a UK Sexual Health and HIV Clinic: A Cross-Sectional Questionnaire Study.
AIDS Behav
; 24(6): 1717-1726, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31664572
11.
Prospective observational study to evaluate the performance of the BioSure HIV Self-Test in the hands of lay users.
Sex Transm Infect
; 94(3): 169-173, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28924053
12.
Randomized controlled trial of the tolerability and completion of maraviroc compared with Kaletra® in combination with Truvada® for HIV post-exposure prophylaxis (MiPEP Trial).
J Antimicrob Chemother
; 72(6): 1760-1768, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28369381
13.
Pharmacokinetics of once-daily doravirine over 72 h following drug cessation.
J Antimicrob Chemother
; 75(6): 1658-1660, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32083675
14.
Systemic inflammation and residual viraemia in HIV-positive adults on protease inhibitor monotherapy: a cross-sectional study.
BMC Infect Dis
; 15: 138, 2015 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25888119
15.
Real world utilisation of doravirine among people living with human immunodeficiency virus in England (DRIVE-REAL).
Int J STD AIDS
; 35(3): 206-216, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37970812
16.
Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV.
AIDS
; 38(4): 521-529, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38061030
17.
Two vicious circles associated with the aging of the immune system in the development of severe forms of COVID-19.
Front Aging
; 4: 1260053, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37780864
18.
Sleep disturbances and their correlation with cardiovascular risk, obesity, and mood disorders in people with HIV.
AIDS
; 37(6): 925-934, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36723511
19.
HIV pre-exposure prophylaxis and its implementation in the PrEP Impact Trial in England: a pragmatic health technology assessment.
Lancet HIV
; 10(12): e790-e806, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38040478
20.
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2.
EClinicalMedicine
; 56: 101823, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36684396